IL33 and atherosclerosis: In the same way, it was reported that deficiency of the endogenously produced IL-33 and its receptor ST2 did not impact the development of atherosclerosis in ApoE-deficient mice [30] while the administration of exogenous IL-33 reduces the development of atherosclerosis [31].